Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

GLYCOMED RIGHTS TO DRUG DELIVERY METHOD

March 4, 1992

GI AND AHP TARGET SMALL MOLECULES

March 4, 1992

LIPO EXPANDS PHASE II TRIALS

March 4, 1992

XOMA PATENT FOR MAB LINKERS

March 4, 1992

MORE TARGETS FOR BT PEST CONTROL

March 3, 1992

XOMA BRISTLES AFTER NEGATIVE E5 ANALYSIS

March 3, 1992

XOMA, RIBI'S NEW SEPSIS TREATMENTS

March 3, 1992

FUNDS OVERSUBSCRIBE VICAL PLACEMENT

March 3, 1992

CAL BIO CHANGES NAME AND TICKER

March 3, 1992

SYNTRO FILES 3 MILLION-SHARE OFFERING

March 3, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...